CCWM
CRBP icon

Cassaday & Co Wealth Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Cassaday & Co Wealth Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113 Buy
+12
New +$101 ﹤0.01% 1321

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cassaday & Co Wealth Management's CRBP Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 12 shares worth $113. The stake represents ﹤0.01% of the portfolio and ranks #1321 among its holdings.

107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Cassaday & Co Wealth Management held 12 shares of Corbus Pharmaceuticals worth $113 as of Q1 2026.
  • Corbus Pharmaceuticals was a new Cassaday & Co Wealth Management position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #1321 holding.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.